3240-35-5 Usage
Description
Benzenesulfonamide, 4-formyl(9CI) is an organic compound with the molecular formula C7H7NO3S. It is a derivative of benzenesulfonamide, featuring a formyl group (-CHO) at the 4-position. Benzenesulfonamide, 4-formyl(9CI) is characterized by its potential reactivity and versatility in chemical synthesis, making it a valuable intermediate for various applications.
Uses
Used in Pharmaceutical Industry:
Benzenesulfonamide, 4-formyl(9CI) is used as an intermediate in the synthesis of various pharmaceutical compounds. Its presence as an impurity in the synthesis of Mafenide (M110200), an antibacterial, highlights its importance in the development of new drugs with potential antibacterial properties.
Used in Chemical Synthesis:
Benzenesulfonamide, 4-formyl(9CI) serves as a versatile building block in the synthesis of a wide range of chemical compounds. Its reactivity and functional groups make it a valuable precursor for the development of new molecules with diverse applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 3240-35-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,2,4 and 0 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3240-35:
(6*3)+(5*2)+(4*4)+(3*0)+(2*3)+(1*5)=55
55 % 10 = 5
So 3240-35-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H7NO3S/c8-12(10,11)7-3-1-6(5-9)2-4-7/h1-5H,(H2,8,10,11)
3240-35-5Relevant articles and documents
Syntheses of aromatic aldehydes by catalytic hydrogenation of nitriles
Tinapp,Moeltgen
, p. 766 - 768 (1976)
-
PRO-DRUG FORMING COMPOUNDS
-
Page/Page column 44, (2015/02/02)
Various prodrug compounds having the general structure: Active agent- (acid)-(linker) - SO2NR1R2 are described herein. Compounds having this general structure were shown to be more orally active than the unmodified parent molecule.
SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS
-
Page/Page column 72, (2013/10/22)
The present invention belongs to the field of EPl receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EPl receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EPl receptor as well as to pharmaceutical compositions comprising them.